Associate Director
Vaxcyte
Associate Director
Vaxcyte
Develops broad-spectrum vaccines for bacterial infections
This role within Technical Operations’ Commercialization Capabilities and Strategic Projects function is critical for building and strengthening the business operations, data, digital tools, and performance insights that help Technical Operations leaders make better decisions, allocate resources effectively, anticipate risks, and execute with greater clarity as the organization advances toward commercialization and future growth.
This role creates an integrated view of Technical Operations priorities, capacity, risks, dependencies, progress, and performance, while identifying opportunities to simplify and automate how the organization works. Working across Technical Operations and with teams across Vaxcyte, this role will translate business needs into practical, scalable solutions that improve visibility, decision-making, and organizational performance.
The successful candidate combines strong business judgment with analytical, systems, and digital fluency. This is not simply a reporting or technology role; it calls for someone who understands how the business operates, can turn data into actionable insight, and can apply systems, automation, analytics, and AI to strengthen the organization’s ability to scale.
Business Operations & Portfolio Management:
Performance Insights & Decision Support:
Digital Enablement, Automation & AI:
Cross-Functional Integration & Capability Building:
Equal Opportunity
We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status.
Recruitment Fraud Notice
Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent Vaxcyte in recruitment activities. Vaxcyte has an established recruitment process for all positions prior to issuing an offer for employment and we will never extend unsolicited employment offers or ask candidates to provide financial or sensitive personal information as part of the application process. All legitimate communication from Vaxcyte will come from an official @vaxcyte.com email address. Qualified and interested candidates should apply to current openings at vaxcyte.com/careers.
Vaxcyte develops vaccines to prevent bacterial infections, focusing on broad-spectrum pneumococcal vaccines and other targets like Group A Strep, periodontitis, and Shigella. Its lead product, VAX-24, covers 24 Streptococcus pneumoniae strains and is produced using the XpressCF cell-free protein synthesis platform, which enables multi-strain conjugate vaccines. The company differentiates itself by combining cell-free manufacturing with broad strain coverage and has FDA Breakthrough Therapy designation for VAX-24, helping speed development. Its goal is to bring broadly protective bacterial vaccines to market, reduce serious infections worldwide, and expand its portfolio with products like VAX-31 and additional preclinical candidates.
Explore more opportunities at Vaxcyte